Epick Drugs Private Limited - Company Profile

It is a paper private limited company based in Panchkula, Haryana, India, established in 2024.
2024 Panchkula, Haryana, India Active
Last Updated:
Access Report
About Epick Drugs Private Limited

Epick Drugs Private Limited, a active private limited company, was established on 17 May 2024 in Panchkula, Haryana, India. Engaging in manufacturing within the paper sector, it holds CIN: U21009HR2024PTC121657. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹1.00 Cr.

Its leadership includes Lakshay Goyal (Director), Madhu Goyal (Director), Aastha (Director). Past directors included Lakshay Goyal, Madhu Goyal. It holds ₹4.85 Cr open charges and no settled loans. It is based at Cabin No-11, First Floor, Plot No 315 1/A, Phase-2, Panchkula, Haryana, 134113.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U21009HR2024PTC121657

  • Registration Number

    121657

  • Incorporation Date

    17 May 2024

  • Authorized Capital

    ₹1.00 Cr

  • Paid-Up Capital

    ₹1.00 Cr

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 Cr
  • Paid Up Capital ₹ 1.00 Cr
  • Company Age 1 Year 9 Months
  • Open Charges ₹ 4.85 Cr
Company report

Epick Drugs Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Epick Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Epick Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Lakshay Goyal Director 17 May 2024 Current
Madhu Goyal Director 17 May 2024 Current
Aastha Director 17 May 2024 Current
Samarveer Chawla Additional Director 26 May 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 30 Jun 2025 Past
Pramod Abcsdd Director 30 Jun 2025 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Epick Drugs.
Epick Drugs revenue growth over time
Epick Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Epick Drugs?

Unlock access to Epick Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹48,500,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Others : 4.85 Cr
Latest Charge Details
Date Lender Amount Status
23 Jan 2025 Others ₹4.85 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Epick Drugs?

Unlock and access historical data on people associated with Epick Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Epick Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Epick Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Epick Drugs
Recent Activity within the Organization
  • Director Appointment

    Progress on Samarveer Chawla was appointed as a Additional Director was appointed as a Additional Director on 26 May 2025 & has been associated with this company since 8 months 27 days . was documented.

  • Charges

    The activity A charge with Others amounted to Rs. 4.85 Cr with Charge ID 101048571 was registered on 23 Jan 2025. was completed.

  • Director Appointment

    Progress on Lakshay Goyal was appointed as a Director was appointed as a Director on 17 May 2024 & has been associated with this company since 1 year 9 months . was documented.

  • Director Appointment

    Madhu Goyal was appointed as a Director was appointed as a Director on 17 May 2024 & has been associated with this company since 1 year 9 months . was recorded as a recent event.

  • Director Appointment

    Progress on Aastha was appointed as a Director was appointed as a Director on 17 May 2024 & has been associated with this company since 1 year 9 months . was documented.

  • Company Incorporation

    The activity Epick Drugs Private Limited was registered on 17 May 2024 with Roc Delhi & aged 1 year 9 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Epick Drugs Private Limited?

The CIN of Epick Drugs Private Limited is U21009HR2024PTC121657.

Where is Epick Drugs Private Limited headquartered?

Epick Drugs Private Limited is headquartered at Cabin No-11, First Floor, Plot No 315 1/A, Phase-2, Panchkula, Haryana, 134113.

When was Epick Drugs Private Limited incorporated?

Epick Drugs Private Limited was incorporated on 17 May 2024.

Who are the current directors of Epick Drugs Private Limited?

The current directors of Epick Drugs Private Limited are

What is the primary industry of Epick Drugs Private Limited?

The primary industry of Epick Drugs Private Limited is Paper.

Is Epick Drugs Private Limited a listed company?

Epick Drugs Private Limited is unlisted.

What is the capital structure of Epick Drugs Private Limited?

The authorized capital of Epick Drugs Private Limited is ₹1.00 Cr, and the paid-up capital is ₹1.00 Cr.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available